Kirin iMUSE Immune Care and Healthya Visceral Fat Down will go on sale on Tuesday November 28!

A special dual-care functional food product from iMUSE, our immune care brand, and Healthya, a visceral fat care brand TOKYO–(BUSINESS WIRE)–Nov. 27, 2023 Kirin Holdings Company, Limited (TOKYO:2503) will launch a dual-care functional food supplement Kirin iMUSE Immuno-Care and Healthya Visceral Fat Down on November 28 (Tuesday). This product is a collaboration between Kirin iMUSE, […]

Japan’s First Discovery*1 on Visceral Fat and Immune Activity in Joint Research by Kirin Holdings and Kao

TOKYO–(BUSINESS WIRE)–Nov. 27, 2023 Kirin Holdings Company, Limited (TOKYO:2503) and Kao Corporation (TOKYO:4452) will participate in the Wakayama Health Promotion Study, a cohort study*2 led by Wakayama Medical University and organized by the Health Promotion Research Center (HPRC), a non-profit organization. Kao and Kirin Holdings conducted a joint study from November 2022 to investigate the […]

AstraZeneca launches Evinova a health-tech business to accelerate innovation across the life sciences sector the delivery of clinical trials and better health outcomes

Evinova will operate as a separate health-tech business within AstraZeneca Evinova’s globally-scaled digital health solutions are evidence-led, science-based and human experience-driven to serve clinical trial sponsors, clinical research organisations (CROs), clinical trial site care teams and patients First strategic collaborations with globally-leading CROs Parexel and Fortrea enable Evinova’s digital health solutions to be offered to […]

SMK Entered into Capital and Business Alliance Agreement with Canary Speech (US)

Acquired Exclusive Commercialization and Distribution Rights for Speech-based Analytic Technology for Diseases such as Dementia in Japanese and Asian Market TOKYO–(BUSINESS WIRE)–Nov. 16, 2023 SMK Corporation (TOKYO: 6798) ( (President, CEO and COO: Yasumitsu Ikeda, hereinafter referred to as SMK) announced that it has entered into a capital and business alliance agreement with Canary Speech, […]

Ketamine Clinic in Japan for Inbound Medical Treatment: Nagoya Anesthesia Clinic

NAGOYA, Japan–(BUSINESS WIRE)–Nov. 14, 2023 Nagoya Anesthesia Clinic (, located in Nagoya City, Aichi Prefecture, Japan, has initiated inbound medical treatment for treatment-resistant depression, other mental disorders, and intractable chronic pain, utilizing the groundbreaking drug Ketamine. Over the past 15 years, the clinic has provided ketamine therapy through more than 1300 ketamine infusions. Our distinctive […]

PHC Corporation Announces that Indonesia-based Life Science Equipment Subsidiary Established in March by PHC Group Will Begin Full-scale Operations

— PT PHC Sales Indonesia will support expansion of PHCbi life science equipment business in Southeast Asia — TOKYO–(BUSINESS WIRE)–Nov. 14, 2023 PHC Corporation’s Biomedical Division (headquarters: Minato-ku, Tokyo, President: Nobuaki Nakamura, hereafter Biomedical Division), provider of PHCbi-branded products including ultra-low temperature freezers and CO2 incubators, announced today that a new subsidiary in Indonesia established […]

Parse Biosciences Extends Global Reach with India-based Spinco Biotech Partnership

SEATTLE–(BUSINESS WIRE)–Nov. 07, 2023 Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with India-based Spinco Biotech to further extend its reach in Asia. This is Parse’s latest expansion in the APAC region following an agreement last year with Research Instruments Pte Ltd to distribute its products […]

Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma

MALVERN, Pa. & CHONGQING, China–(BUSINESS WIRE)–Nov. 01, 2023 Resolian, a global bioanalytical contract research organization (CRO) specializing in drug metabolism and pharmacokinetics for small and large molecules, has acquired Denali Medpharma, a leading China-based bioanalytical CRO. Resolian now has bioanalysis laboratory operations in the U.S., U.K., Australia, and China. The company can initiate a project […]

Medisca Expands Strategic Partnerships to Drive Patient Access to Critical Medications

MONTREAL–(BUSINESS WIRE)–Jul. 27, 2023 Medisca has announced the expansion of a network of strategic partnerships aimed at securing and stabilizing worldwide access to high quality active pharmaceutical ingredients (APIs) for the preparation of essential medications. This mission started with the exclusive partnership for Thyroid USP in 2021, and has now expanded to include Progesterone USP […]

China Industry-University-Research-Medicine Shines at the Top of the World: BOTANEE 2023 International Skin Health Summit Closed

SINGAPORE–(BUSINESS WIRE)–Jul. 12, 2023 "In 2015, we made our first appearance in Vancouver WCD with the main brand WINONA. After eight years, WINONA has now become the leading brand of functional skin care products in China. Invited to participate in WCD for three times this year, we brought four core brands. I hope that after […]

SciMed (Asia) Life Science Sales and Service Distributing Subsidiary of PHC Holdings Corporation Becomes Wholly Owned Subsidiary — Acquisition Expands PHC Group’s Business Supporting Researchers and Healthcare Providers in Asia-Pacific —

TOKYO–(BUSINESS WIRE)–Jun. 15, 2023 PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) announces that it has acquired the remaining 30% stake in its subsidiary SciMed (Asia) Pte. Ltd. (headquarters: Singapore, hereafter SciMed), making SciMed a wholly owned subsidiary of PHCHD. PHCHD previously owned a 70% stake in […]

ANANDA Scientific Announces First Patient Enrolled in FDA-approved Clinical Trial Evaluating a Potential New Treatment for Social Anxiety Disorder (SAD)

NEW YORK & GREENWOOD VILLAGE, Colo.–(BUSINESS WIRE)–Mar. 28, 2023 ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced that the first subject has been enrolled in the clinical trial with an FDA-approved IND evaluating Nantheia™ A1002N5S, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary Liquid Structure™ delivery technology as a potential treatment for […]